This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie Grant Agreement No. 956851.

Sydney Mwasambu at the 3rd Nordic Metabolomics Society conference

Sydney Mwasambu, COLOTAN Early Stage Researcher and PhD student at Uppsala University in Prof. Daniel Globisch’s group, shared their recent developments of their chemoselective probe technology at the 3rd Nordic Metabolomics Society conference.